Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects-Reference-Cited by-同舟云学术

Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects

Published:2013-04-05 Issue:3 Volume:28 Page:205-214
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Cabaleiro Teresa¹,López-Rodríguez Rosario,Ochoa Dolores¹,Román Manuel¹,Novalbos Jesús¹,Abad-Santos Francisco

Affiliation:

1. Clinical Pharmacology Service; Hospital Universitario de la Princesa, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria Princesa (IP); Madrid; Spain

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference49 articles.

1. Differences between men and women in side effects of second-generation antipsychotics;Aichhorn;Nervenarzt,2007

2. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers;Albaugh;PLoS One,2011

3. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting;Alenius;J Psychiatr Res,2008

4. Evaluating a newly developed pharmacogenetic array: screening in a Spanish population;Almoguera;Pharmacogenomics,2010

5. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics;Anderson;J Womens Health (Larchmt),2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism;Frontiers in Pharmacology;2024-02-05

3. Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions;Pharmacogenomics and Personalized Medicine;2023-12

4. Sex-specific differences and similarities of olanzapine and risperidone on avoidance suppression in rats in the conditioned avoidance response test;Brain Research;2023-11

5. UGT1A polymorphism rs4148324 associated with topiramate plasma concentration to dose ratio in children with epilepsy;Seizure: European Journal of Epilepsy;2023-10